Company / FCF Margin
FATE THERAPEUTICS INC FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-906.8%
FY2025
5-year range
-906.8% / -140.5%
FY2021-FY2025
Trend
-316.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin changed -316% YoY in FY2025, a notable deviation from the 8-year average annual change of -35%.
Based on SEC 10-K filings.
-906.8% in FY2025 with a 5-year CAGR of -42.8%.
Declined from -294.7% to -906.8% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -766.3pp
- 5-Year Change
- -42.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin decreased 316.2% year-over-year.
- Peak fcf margin was recorded in FY2022.
- Lowest fcf margin in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -906.8% | -316.2% |
| FY2024 | -217.9% | +26.1% |
| FY2023 | -294.7% | -109.8% |
| FY2022 | -140.5% | +83.4% |
| FY2021 | -848.0% | +1.8% |
| FY2020 | -864.0% | +8.0% |
| FY2019 | -938.7% | -36.5% |
| FY2018 | -687.9% | - |
| FY2017 | - | - |
| FY2016 | -1762.6% | -9.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026